This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Successfully funded
overfunded
Molecular Warehouse
154%
Raised
£154,310
Investors
115
Target
£100,000
Equity
1.08%
Pre-money valuation
£14,085,217

Molecular Warehouse, backed by Oxford Technology, has a disruptive, patented biosensor technology designed to enable people to monitor their health using their smartphones. Since their last raise, has had patents granted, and signed a partnership with an international Pharma company.

  • Partnership signed with international pharmaceutical company
  • Experienced team and backing from specialised VCs
  • This pitch is private and limited to existing investors
  • The information below has not been verified by Crowdcube
Information This is a private pitch open to the company's existing investors only. It is therefore not necessary for Crowdcube to approve this pitch as a financial promotion. As Crowdcube has not carried out any due diligence on this pitch, the Due Diligence Charter does not apply. Investors should carry out their own due diligence and take professional advice where necessary.

Idea

Our vision is to create a world where most diseases are prevented, by giving people the ability to monitor and manage their health using their smartphones, anywhere, anytime.

We have used synthetic biology to re-engineer the most successful personal diagnostic system, the glucose monitor, which millions of diabetic patients use every day, to be able to detect many other diseases.

Initial applications currently in development target chronic kidney disease, which affects almost 10% of the population worldwide, hemophilia, chronic stress, vitamin D levels, and acute pancreatitis.

Our innovative system is protected by six international patents, and we have unique proprietary assets in synthetic biology, electronics, software algorithms, and data encryption and patient privacy.

KEY PROGRESS SINCE LAST CROWDCUBE ROUND:

> Signed a partnership with an international Pharma company, which included a £215,000 upfront fee and contains over £10m in technical- and sales-based milestone payments

> Developed fully working pre-manufacturing prototype of our Bluetooth-enabled test reader

> Moved to automated manufacturing for our test strips

> Recruited 6 new employees and moved to purpose-built laboratories at the Surrey Research Park

> Filed one new patent, and had two patents granted in USA and one granted in Europe

> Successfully passed ISO13485 & ISO9001 level 1 audit

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Molecular Warehouse pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered? Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Molecular Warehouse has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.